Kara M. Smith, MD, MSCI
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Neurology




Dr. Kara M. Smith is Division Chief of the Movement Disorders Division in the Department of Neurology at Boston Medical Center and a Clinical Associate Professor at Boston University Chobanian and Avedisian School of Medicine. She currently serves as the Program Director of the Movement disorders Fellowship Program at Boston Medical Center. She is board-certified in Neurology and is a fellowship-trained Movement disorders Specialist.

Dr. Smith completed a Neurology residency at Beth Israel Deaconess Medical Center/Harvard Medical School. She completed her Movement disorders Fellowship at the Perelman School of Medicine at the University of Pennsylvania. She currently provides clinical care for patients living with Parkinson’s disease, atypical parkinsonism, tremor, tics, chorea, and dystonia at Boston Medical Center and BU Neurology Associates. She has experience with deep brain stimulation utilization and programming, and also provides botulinum toxin injections for Movement disorders. Her approach to patient care is personalized, whole-person centered, and she strives to incorporate the latest evidence and technologies to benefit all patients with Movement disorders.

As a clinician-scientist dedicated to advancing clinical research in Parkinson’s disease, Dr. Smith has over ten years of research experience. She earned a M.S. in Clinical Investigation at the Morningside Graduate School of Biomedical Sciences at the University of Massachusetts. She is a credentialed investigator of the Parkinson Study Group, and has served as PI on numerous industry-sponsored clinical trials.

Her research is focused on cognitive impairment and speech/communication symptoms in Parkinson’s disease. She is also interested in novel technologies to remotely monitor patients with Movement disorders, and the effects of pharmacologic and non-pharmacologic therapies, including music therapy and exercise, on these disorders. She has been awarded research funding from the National Institutes of Health, the Michael J. Fox Foundation, and philanthropic donors.

Chief
Boston University Chobanian & Avedisian School of Medicine
Neurology
Movement Disorders Division

Medical Director
Boston University Chobanian & Avedisian School of Medicine
Parkinson’s Disease and Movement Disorders Center



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Smith KM, Saranathan M. Imaging in Movement Disorders: A Clinician's Perspective on Novel Applications. Semin Neurol. 2025 Dec 26. PMID: 41453371; DOI: 10.1055/a-2769-6508;
     
  2. Dahl KL, Balz MA, Smith KM, Stepp CE. Preliminary Psychometric Review of Neurologists' Speech Ratings on the Unified Parkinson's Disease Rating Scale. Am J Speech Lang Pathol. 2025 Nov 18; 1-10. PMID: 41253127; DOI: 10.1044/2025_AJSLP-25-00168;
     
  3. DeSilva GS, Upadhyay P, Manxhari M, Gopal D, Smith KM. Variability in Vowel Space in Parkinson's Disease: Associations With Cognitive and Motor Impairment. J Speech Lang Hear Res. 2024 Oct 08; 67(10):3566-3578. PMID: 39259881; PMCID: PMC11482582; DOI: 10.1044/2024_JSLHR-24-00008;
     
  4. Smith KM, Demers-Peel M, Manxhari C, Stepp CE. Voice Acoustic Instability During Spontaneous Speech in Parkinson's Disease. J Voice. 2025 Nov; 39(6):1697.e1-1697.e9.View Related Profiles. PMID: 37500359; PMCID: PMC10808279; DOI: 10.1016/j.jvoice.2023.06.004;
     
  5. Andrade EIN, Manxhari C, Smith KM. Pausing before verb production is associated with mild cognitive impairment in Parkinson's disease. Front Hum Neurosci. 2023; 17:1102024. PMID: 37113321; PMCID: PMC10126398; DOI: 10.3389/fnhum.2023.1102024;
     
  6. Palacios N, Hannoun A, Flahive J, Ward D, Goostrey K, Deb A, Smith KM. Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease. Front Neurol. 2021; 12:574529. PMID: 33746867; PMCID: PMC7970035; DOI: 10.3389/fneur.2021.574529;
     
  7. Josephy-Hernandez S, Norise C, Han JY, Smith KM. Survey on Acceptance of Passive Technology Monitoring for Early Detection of Cognitive Impairment. Digit Biomark. 2021; 5(1):9-15. PMID: 33615117; PMCID: PMC7879311; DOI: 10.1159/000512207;
     
  8. Ngo AB, Smith KM. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease. J Parkinsons Dis. 2020; 10(4):1695-1698. PMID: 32925096; PMCID: PMC7814400; DOI: 10.3233/JPD-202110;
     
  9. Smith KM, Caplan DN. Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language. Brain Lang. 2018 Oct; 185:38-46. PMID: 30092448; DOI: 10.1016/j.bandl.2018.08.002;
     
  10. Smith KM, Ash S, Xie SX, Grossman M. Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease. J Speech Lang Hear Res. 2018 Jul 13; 61(7):1691-1699. PMID: 29955824; PMCID: PMC6195062; DOI: 10.1044/2018_JSLHR-L-17-0304;
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 10 distinct years, with a maximum of 4 publications in 2014

YearPublications
20111
20144
20153
20161
20182
20202
20211
20232
20241
20252


2023 UMass Memorial Medical Healthcare Group/ University of Massachusetts Chan Medical School, Worcester,: Prize for Academic Collaboration and Excellence (PACE Prize)
2016 University of Massachusetts Chan Medical School, Worcester, MA: Faculty Scholar Award
Contact for Mentoring:

Smith's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department